Rita Jain - 20 May 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Role: EVP, Chief Medical Officer, Director
Signature: /s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 20 May 2022
Net transactions value: $0
Form type: 4
Filing time: 24 May 2022, 19:27:53 UTC
Previous filing: 29 Mar 2022
Next filing: 24 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCXI	Common Stock	Options Exercise	$0	+7,726	+27%	$0.000000	35,863	20 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CCXI	Restricted Stock Units	Options Exercise		-7,726	-100%		0	20 May 2022	Common Stock	7,726		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.
F2	Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F3	100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.